|
Austria-MB-MB Azienda Directories
|
Azienda News:
- What is Immuno-Oncology: The Next 3 Big Advancements in Cancer . . . - Zonia
Immuno-oncology, also known as “cancer immunotherapy”, is an approach to treating cancer “that uses the power of the body’s own immune system to prevent, control, and eliminate cancer ” The human immune system is incredibly powerful, and has the ability to neutralize and eradicate a wide range of pathogens and harmful chemicals
- Advances in cancer immunotherapies - Cell Press
Therapeutic modalities that engage the immune system to recognize and eliminate cancer, known as cancer immunotherapy, has emerged as a distinct pillar of cancer therapy Among the most promising treatment approaches are therapeutic vaccines, immune checkpoint blockade, bispecific T-cell engagers (BiTEs) and adoptive cell therapies These approaches share a common mechanism of action, which is
- Center for Immuno-Oncology | Center for Cancer Research
The CCR’s Center for Immuno-oncology (CIO) explores fundamental questions of cancer immunotherapy through rigorous preclinical studies and translates these findings into clinical trials with the goal of developing novel therapies for a spectrum of cancers CCR’s long history of excellence in immunology has contributed to advances in immunotherapies now widely used to treat many patients
- Understanding innovation and advancements in immunotherapy - AstraZeneca
Immuno-oncology has grown exponentially over the last decade and is transforming outcomes for patients At AstraZeneca, we are exploring innovative ways to empower the body’s immune system to fight cancer, such as novel multispecific antibodies and next-generation immune cell engagers, including our pioneering trispecific CD8+ selective T-cell engager platform
- Emerging trends in immunotherapy and cancer | CAS
Immuno-oncology (IO) therapy has ushered in a new era by harnessing the body's innate defenses to combat cancer cells and has already proven effective in treating bladder, breast, and colorectal cancers, among others As with any cutting-edge field, the landscape of IO therapy is vast and multifaceted
- Immuno-Oncology at the Forefront of Cancer Medicine
Immuno-oncology has already transformed cancer treatment, but the next decade will see even greater advancements Personalized immunotherapies, AI-driven drug development, and gene editing technologies will drive new breakthroughs, while efforts to reduce costs and expand access will determine how widely these innovations benefit patients
- ADVANCEMENTS IN IMMUNO-ONCOLOGY - Aranca
ADVANCEMENTS IN IMMUNO-ONCOLOGY CURRENT OVERVIEW OF IMMUNO-ONCOLOGY CURRENT APPROVED IMMUNO-ONCOLOGY LANDSCAPE TRIAL ANALYSIS: Between 2017 and August 2020, immuno-oncology (IO) agents increased by 233%, totaling 4,720 across six categories, I Global Immuno-oncology Drug Development Pipeline II Clinical Unmet Needs Personalized Care
- Reporting on the Latest Advancements and Data in IO: Immuno-Oncology . . .
In this special report, we provide a summary of the highlights from the 10th annual Immuno-Oncology 360º March 29, 2024 Marking a decade of IO360°, the IO360º summit brought together leaders from the science and business communities for a comprehensive program focused on data-driven advancements in immuno-oncology
- Oncology Breakthroughs - ESMO Congress 2024 | Medpace
Immuno-oncology continues to lead advancements in cancer treatment, with new approaches expanding beyond traditional checkpoint inhibitors The user of biomarker-driven approaches, such as PD-L1 expression and tumor mutational burden, is refining patient selection and improving therapeutic outcomes
- Advances and Challenges in Interventional Immuno-Oncology Locoregional . . .
The interventional immuno-oncology subspecialty of IR is at the forefront of advancements in cancer therapeutics, particularly in the delivery of immunotherapies The field is rapidly evolving, with innovative materials such as LATTE and SEM offering new possibilities for targeted drug delivery
|
|